Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Shares Outstanding (Diluted Average): 2016-2020

Historic Shares Outstanding (Diluted Average) for Outlook Therapeutics (OTLK) over the last 3 years, with Jun 2020 value amounting to $90.8 million.

  • Outlook Therapeutics' Shares Outstanding (Diluted Average) was N/A to $90.8 million in Q2 2020 from the same period last year, while for Jun 2020 it was $90.8 million, marking a year-over-year change of. This contributed to the annual value of $39.5 million for FY2018, which is 64.12% up from last year.
  • As of Q2 2020, Outlook Therapeutics' Shares Outstanding (Diluted Average) stood at $90.8 million, which was up 130.01% from $39.5 million recorded in Q3 2018.
  • Over the past 5 years, Outlook Therapeutics' Shares Outstanding (Diluted Average) peaked at $90.8 million during Q2 2020, and registered a low of $14.2 million during Q1 2016.
  • For the 2-year period, Outlook Therapeutics' Shares Outstanding (Diluted Average) averaged around $47.6 million, with its median value being $37.0 million (2018).
  • Data for Outlook Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 68.15% (in 2017) over the last 5 years.
  • Quarterly analysis of 4 years shows Outlook Therapeutics' Shares Outstanding (Diluted Average) stood at $17.2 million in 2016, then spiked by 39.67% to $24.0 million in 2017, then surged by 64.12% to $39.5 million in 2018, then reached $90.8 million in 2020.
  • Its last three reported values are $90.8 million in Q2 2020, $39.5 million for Q3 2018, and $34.5 million during Q2 2018.